Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

被引:410
|
作者
Takahashi, Yoshihisa [1 ]
Soejima, Yurie [1 ]
Fukusato, Toshio [1 ]
机构
[1] Teikyo Univ, Sch Med, Dept Pathol, Itabashi Ku, Tokyo 1738605, Japan
关键词
Animal model; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Metabolic syndrome; Histopathology; ACTIVATED-RECEPTOR-ALPHA; CHOLINE-DEFICIENT DIET; METHIONINE ADENOSYLTRANSFERASE 1A; FRUCTOSE-ENRICHED DIETS; INSULIN-RESISTANCE; METABOLIC SYNDROME; DB/DB MICE; HEPATIC INFLAMMATION; OXIDATIVE STRESS; NATURAL-HISTORY;
D O I
10.3748/wjg.v18.i19.2300
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is a condition in which excess fat accumulates in the liver of a patient without a history of alcohol abuse. Nonalcoholic steatohepatitis (NASH), a severe form of NAFLD, can progress to liver cirrhosis and hepatocellular carcinoma. NAFLD is regarded as a hepatic manifestation of metabolic syndrome and incidence has been increasing worldwide in line with the increased prevalence of obesity, type 2 diabetes, and hyperlipemia. Animal models of NAFLD/NASH give crucial information, not only in elucidating pathogenesis of NAFLD/NASH but also in examining therapeutic effects of various agents. An ideal model of NAFLD/NASH should correctly reflect both hepatic histopathology and pathophysiology of human NAFLD/NASH. Animal models of NAFLD/NASH are divided into genetic, dietary, and combination models. In this paper, we review commonly used animal models of NAFLD/NASH referring to their advantages and disadvantages. (c) 2012 Baishideng. All rights reserved.
引用
收藏
页码:2300 / 2308
页数:9
相关论文
共 50 条
  • [1] Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Yoshihisa Takahashi
    Yurie Soejima
    Toshio Fukusato
    World Journal of Gastroenterology, 2012, (19) : 2300 - 2308
  • [2] Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Takahashi, Yoshihisa
    Fukusato, Toshio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (42) : 15539 - 15548
  • [3] Pathogenesis of and major animal models used for nonalcoholic fatty liver disease
    Jiang, Mingzuo
    Wu, Nan
    Chen, Xi
    Wang, Weijie
    Chu, Yi
    Liu, Hao
    Li, Wenjiao
    Chen, Di
    Li, Xiaowei
    Xu, Bing
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (04) : 1453 - 1466
  • [4] Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
    Massoud, Omar
    Charlton, Michael
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 201 - +
  • [5] Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation
    Carter, Danielle
    Dieterich, Douglas T.
    Chang, Charissa
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 213 - +
  • [6] Rodent Models of Nonalcoholic Fatty Liver Disease
    Zhong, Fang
    Zhou, Xiaoming
    Xu, Jin
    Gao, Ling
    DIGESTION, 2020, 101 (05) : 522 - 535
  • [7] Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Takahashi, Yoshihisa
    Sugimoto, Keiichiro
    Inui, Hiroshi
    Fukusato, Toshio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (13) : 3777 - 3785
  • [8] Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems
    Tiniakos, Dina G.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (06) : 643 - 650
  • [9] Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
    Imajo, Kento
    Yoneda, Masato
    Kessoku, Takaomi
    Ogawa, Yuji
    Maeda, Shin
    Sumida, Yoshio
    Hyogo, Hideyuki
    Eguchi, Yuichiro
    Wada, Koichiro
    Nakajima, Atsushi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (11) : 21833 - 21857
  • [10] The Differentiation of Intestinal-Failure-Associated Liver Disease from Nonalcoholic Fatty Liver and Nonalcoholic Steatohepatitis
    Buchman, Alan L.
    Naini, Bita V.
    Spilker, Bert
    SEMINARS IN LIVER DISEASE, 2017, 37 (01) : 33 - 44